GE HealthCare has received FDA Premarket Authorization for Pristina Recon DL, an innovative 3D mammography reconstruction application. Powered by artificial intelligence (AI), Pristina Recon DL ...
Exploring the utility of prostate-derived extracellular vesicles as a urine biomarker for clinically significant prostate cancer. This is an ASCO Meeting Abstract from the 2024 ASCO Genitourinary ...
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the FDA clearance and launch of Sonic DL – a state-of-the-art deep learning-based technology designed to dramatically accelerate ...
More than 80 percent of all health system visits include an imaging exam,i making radiology an essential part of diagnostics and healthcare and image quality a cornerstone of medicine. GE HealthCare ...
A new study published in PNAS Nexus by researchers at Carnegie Mellon University (CMU) demonstrates how a noninvasive brain-computer interface (BCI) powered by artificial intelligence (AI) deep ...
Artificial Intelligence (AI) has become an integral part of modern technology, transforming various industries by simulating human intelligence through computers. This guide delves into the world of ...
Endoscopy-based deep learning algorithms demonstrate higher sensitivity and specificity than endoscopists overall in detecting early esophageal squamous cell carcinoma.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results